FDA to review company responses to inspection reports
This article was originally published in The Silver Sheet
Executive Summary
FDA will now consider manufacturer responses to FDA-483 inspection forms received within 15 days of the form's issuance when deciding whether to send a warning letter, FDA says in an Aug. 11 Federal Register notice. However, the agency notes that timely responses will not necessarily preclude it from issuing a warning letter. And the 15-day response deadline is firm: "The agency will not ordinarily delay the issuance of a warning letter in order to review a response to an FDA-483 that is received more than 15 business days after the FDA-483 was issued," the FR notice says. FDA plans to test out the response review program for 18 months and then decide whether to make it permanent
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.